| Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report |
174 |
| Air Pollution and Noncommunicable Diseases A Review by the Forum of International Respiratory Societies' Environmental Committee, Part 2: Air Pollution and Organ Systems |
70 |
| Too Many Patients ... A Framework to Guide Statewide Allocation of Scarce Mechanical Ventilation During Disasters |
63 |
| Predicting Survival in Patients With Pulmonary Arterial Hypertension The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies |
60 |
| Air Pollution and Noncommunicable Diseases A Review by the Forum of International Respiratory Societies' Environmental Committee, Part 1: The Damaging Effects of Air Pollution |
59 |
| Therapy for Pulmonary Arterial Hypertension in Adults Update of the CHEST Guideline and Expert Panel Report |
48 |
| Radiation-Induced Lung Injury Assessment and Management |
42 |
| Classification of Cough as a Symptom in Adults and Management Algorithms CHEST Guideline and Expert Panel Report |
42 |
| Screening for Lung Cancer CHEST Guideline and Expert Panel Report |
41 |
| Mucins, Mucus, and Goblet Cells |
34 |
| Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer Benefits and Pulmonary Toxicities |
32 |
| Scarce Resource Allocation During Disasters A Mixed-Method Community Engagement Study |
30 |
| Hypersensitivity Pneumonitis Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory |
30 |
| The Emerging Role of Neutrophil Extracellular Traps in Respiratory Disease |
27 |
| Management of Refractory Vasodilatory Shock |
27 |
| The Association of Frailty With Post-ICU Disability, Nursing Home Admission, and Mortality A Longitudinal Study |
26 |
| Personalized Management Approach for OSA |
26 |
| Secondhand Exposure to Aerosols From Electronic Nicotine Delivery Systems and Asthma Exacerbations Among Youth With Asthma |
25 |
| The Septic Heart Current Understanding of Molecular Mechanisms and Clinical Implications |
25 |
| The Relationship Between COPD and Frailty A Systematic Review and Meta-Analysis of Observational Studies |
25 |
| A Comparison of the Quick-SOFA and Systemic Inflammatory Response Syndrome Criteria for the Diagnosis of Sepsis and Prediction of Mortality A Systematic Review and Meta-Analysis |
25 |
| Standard Bronchoscopy With Fluoroscopy vs Thin Bronchoscopy and Radial Endobronchial Ultrasound for Biopsy of Pulmonary Lesions A Multicenter, Prospective, Randomized Trial |
23 |
| Group 2 Innate Lymphoid Cells in Airway Diseases |
23 |
| Vitamin C Pharmacokinetics in Critically Ill Patients A Randomized Trial of Four IV Regimens |
23 |
| Lung Repair and Regeneration in ARDS Role of PECAM1 and Wnt Signaling |
23 |
| A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects Derivation in 446 Chinese Subjects, With Internal Validation and External Application in 199 Korean Subjects |
22 |
| Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults A Systematic Review and Meta-analysis |
22 |
| Inability of Diaphragm Ultrasound to Predict Extubation Failure A Multicenter Study |
22 |
| Sleep in Women Across the Life Span |
22 |
| Exposure to Ambient Particulate Matter Is Associated With Accelerated Functional Decline in Idiopathic Pulmonary Fibrosis |
22 |
| Vitamin D in Asthma Mechanisms of Action and Considerations for Clinical Trials |
21 |
| Predictors of Mortality in Pulmonary Sarcoidosis |
21 |
| Drug-Induced Sarcoidosis-Like Reactions |
21 |
| Adherence to CPAP What Should We Be Aiming For, and How Can We Get There? |
20 |
| Big Data and Data Science in Critical Care |
20 |
| Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation |
20 |
| Ion Channel Modulators in Cystic Fibrosis |
19 |
| ED Door-to-Antibiotic Time and Long-term Mortality in Sepsis |
18 |
| Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease A Systematic Review |
18 |
| Continuous Renal Replacement Therapy Who, When, Why, and How |
18 |
| Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD |
18 |
| Effectiveness of Reprocessing for Flexible Bronchoscopes and Endobronchial Ultrasound Bronchoscopes |
18 |
| Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-98 a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis |
18 |
| Air Pollution Exposure Is Associated With Lower Lung Function, but Not Changes in Lung Function, in Patients With Idiopathic Pulmonary Fibrosis |
17 |
| Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation A Report From the Taiwan Nationwide AF Cohort Study |
17 |
| Inhaled Tranexamic Acid for Hemoptysis Treatment A Randomized Controlled Trial |
17 |
| Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial |
16 |
| Respiratory Failure in Amyotrophic Lateral Sclerosis |
16 |
| Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS) |
16 |
| A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary Aspergillosis Complicating Asthma |
16 |
